Is Ingevity Corp (NGVT) overvalued? · rev $1.41B
Ingevity Corp (NGVT) is a specialty chemicals company listed on NYSE.
This page asks whether Ingevity Corp (NGVT) looks expensive on cached numbers — not a short thesis.
Latest reported NGVT revenue for 2024-12-31 was $1.41B. Net income was -$430.3M. Revenue was down 16.9% from 2023-12-31 to 2024-12-31. NGVT currently screens at market cap $2.52B.
NGVT currently screens at market cap $2.52B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NGVT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NGVT stock page for the full model, not this heading.
Not investment advice.